Changes in BLIS Board

9 February 2026 Changes in BLIS Board Paul Munro to join the board The Board of BLIS Technologies Limited is pleased to announce the appointment of Paul Munro as an Independent Non-Executive Director of the company. Paul’s appointment is effective from 1 March 2026. Paul has extensive governance experience from a wide range of public and private entities. Prior to his governance career Paul spent 24 years with Deloitte as a Corporate Finance Partner, primarily working with large corporates, leading projects and M&A assignments. Following his time with Deloitte Paul was CEO for Christchurch City Holdings Limited, the holding company for Christchurch City’s $4 billion investment portfolio. Paul is currently an Independent Non-Executive Director of Scales Corporation Limited, where he is Chair of the Audit & Risk Management Committee and New Zealand King Salmon Limited, where he is also Chair of the Audit, Finance, Risk and Project Development Committee. In addition to this role, Paul is currently Chair or a Director of a number of private companies, including Chair of Orion New Zealand Limited, Tait International Limited and Cambridge Partners Limited. BLIS’ Chair Alison Stewart, said “We are excited to welcome Paul to the BLIS Board. Paul brings extensive financial, commercial and governance experience from a wide range of businesses. His skills and experience make him a great replacement and he will be a valuable addition to the Board. In accordance with BLIS’ constitution, Paul will retire from office at the next BLIS Annual Shareholders’ Meeting and will be eligible for election at that meeting. In accordance with Listing Rule 2.6.1, the Board has determined that Paul will be an Independent Director. Retirement of Geoff Plunket As advised to the market in September 2025, Geoff Plunket signalled his intention to stand down from the Board once a replacement had been secured. Geoff will retire on 1 March 2026 after approximately eight years on the Board, including four and a half years as Chair. “Geoff has driven the business’ focus on clear strategic growth initiatives and their delivery. Having also strengthened governance and commercial prioritisation, the company is well positioned to capitalise on the growing global probiotics market. We wish Geoff all the best in his retirement.“ said Chair, Dame Alison Stewart. Ends For further information, please contact: Alison Stewart Chair +64 27 550 0558 About BLIS Technologies Ltd Delivering proven health benefits through evidence-based, advanced probiotics BLIS Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS products are sold throughout New Zealand and in Asia, Europe and the USA. More information about BLIS Technologies Ltd can be found at www.blis.co.nz. Website: www.blis.co.nz Instagram: @blisprobiotics #blisk12 #blism18 #blisq24 Facebook: @BLISProbiotics